JIAClass I
Enzymatic Methods, Galactose
21 CFR 862.1310 / Clinical Chemistry
JIA is the FDA product code for Enzymatic Methods, Galactose, a class I device type, regulated under 21 CFR 862.1310. As of , FDA records hold 9 510(k) clearances under this code, the most recent dated , and 6 recalls.
Classification record
- Product code
- JIA
- Device name
- Enzymatic Methods, Galactose
- Regulation
- 21 CFR 862.1310
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 9
- Ingested recalls
- 6
Clearances, product code JIA
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1995 | 1 |
| 1996 | 1 |
| 1999 | 3 |
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2019 | 1 |
Applicants with the most clearances
Product code JIA| Applicant | Clearances |
|---|---|
| Quantase, Ltd. | 2 |
| Astoria-Pacific, Inc. | 1 |
| Icn Pharmaceuticals, Inc. | 1 |
| Isolab, Inc. | 1 |
| Neometrics, Inc. | 1 |
| Revvity Health Sciences, Inc. | 1 |
| Wallac Oy | 1 |
| Wallac Oy, A Subsidiary of Perkinelmer, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
